{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:20:05Z","timestamp":1790868005923,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.molimm.2006.09.034","type":"journal-article","created":{"date-parts":[[2006,11,20]],"date-time":"2006-11-20T10:42:50Z","timestamp":1164019370000},"page":"1903-1913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates"],"prefix":"10.1016","volume":"44","author":[{"given":"Mario","family":"Di Giambattista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Branckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Hougardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Kemball-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Laub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2006.09.034_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0019-2791(69)90179-7","article-title":"Glutaraldehyde, cyanuric chloride and tetrazotized O-dianisidine as coupling reagents in the passive hemagglutination test","volume":"6","author":"Avrameas","year":"1969","journal-title":"Immunochemistry"},{"key":"10.1016\/j.molimm.2006.09.034_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/biol.2001.0295","article-title":"Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides","volume":"29","author":"Di Giambattista","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.molimm.2006.09.034_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1432-1033.1996.0365h.x","article-title":"Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa: a regulatory role of the factor VIII heavy-chain region Lys713-Arg740","volume":"240","author":"Donath","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molimm.2006.09.034_bib4","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1016\/S0021-9258(18)31537-0","article-title":"Human factor VIIIa subunit structure. Reconstitution of factor VIIIa from the isolated A1\/A3-C1-C2 dimer and A2 subunit","volume":"266","author":"Fay","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2006.09.034_bib5","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1074\/jbc.M104732200","article-title":"Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs","volume":"277","author":"Gilbert","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2006.09.034_bib6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0037-1615080","article-title":"A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detection factor VIII:C inhibitors in the haemophilia A population of Canada","volume":"79","author":"Giles","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1055\/s-0038-1656081","article-title":"Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors","volume":"77","author":"Gilles","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2005-04-1371","article-title":"Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A","volume":"107","author":"Goudemand","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1538-7836.2004.00918.x","article-title":"T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects","volume":"2","author":"Hu","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2516.2004.01031.x","article-title":"Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases","volume":"10","author":"Huang","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.molimm.2006.09.034_bib11","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1046\/j.1538-7836.2003.00088.x","article-title":"Molecular mechanisms of mild and moderate hemophilia A","volume":"1","author":"Jacquemin","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V96.3.958","article-title":"A novel cause of mild\/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor","volume":"96","author":"Jacquemin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0037-1615223","article-title":"Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking","volume":"80","author":"Lapan","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0037-1614415","article-title":"Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain","volume":"81","author":"Laub","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/138161206775193055","article-title":"Autoantibody-induced formation of immune complexes in normal human serum","volume":"12","author":"Lemieux","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.molimm.2006.09.034_bib16","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1074\/jbc.271.4.1935","article-title":"The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX","volume":"271","author":"Lenting","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2006.09.034_bib17","first-page":"463a","article-title":"The factor VIII peptide consisting of amino acids 698 to 712 enhances factor IXa cleavage of factor X","volume":"90","author":"Liles","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/bi00571a022","article-title":"New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates","volume":"18","author":"Liu","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2006.09.034_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V96.3.979","article-title":"Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure","volume":"96","author":"Liu","year":"2000","journal-title":"Blood"},{"issue":"Suppl. 10","key":"10.1016\/j.molimm.2006.09.034_bib20","first-page":"26","article-title":"Mapping factor VIII inhibitor epitopes using hybrid human\/porcine factor VIII molecules","volume":"85","author":"Lollar","year":"2000","journal-title":"Haematology"},{"key":"10.1016\/j.molimm.2006.09.034_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1538-7836.2004.00802.x","article-title":"Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX","volume":"2","author":"Lollar","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood.V73.2.497.497","article-title":"Identification of a F. VIII epitope recognized by a human hemophilic inhibitor","volume":"73","author":"Lubahn","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib23","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V95.11.3435","article-title":"Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG","volume":"95","author":"Moreau","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib24","doi-asserted-by":"crossref","first-page":"33104","DOI":"10.1074\/jbc.M405537200","article-title":"Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain","volume":"279","author":"Nogami","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2006.09.034_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.seminhematol.2003.11.016","article-title":"Environmental and genetic factors influencing inhibitor development","volume":"41","author":"Oldenburg","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molimm.2006.09.034_bib26","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/bi00367a013","article-title":"New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites","volume":"25","author":"Parker","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2006.09.034_bib27","first-page":"347","article-title":"Prediction of surface and interior regions in proteins. Part I. linear tripeptide sequences identify structural boundaries in proteins","volume":"4","author":"Parker","year":"1991","journal-title":"Peptide Res."},{"key":"10.1016\/j.molimm.2006.09.034_bib28","first-page":"355","article-title":"Prediction of surface and interior regions in proteins. Part II: predicting secondary structure in regions bound by surface exposed regions","volume":"4","author":"Parker","year":"1991","journal-title":"Peptide Res."},{"key":"10.1016\/j.molimm.2006.09.034_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0038-1655911","article-title":"Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate","volume":"77","author":"Peerlinck","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1160\/TH03-12-0755","article-title":"Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site","volume":"92","author":"Pratt","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/46601","article-title":"Structure of the C2 domain of human factor VIII at 1.5\u00c5 resolution","volume":"402","author":"Pratt","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2006.09.034_bib32","first-page":"624","article-title":"Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisation","volume":"80","author":"Raut","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1538-7836.2004.00850.x","article-title":"Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII","volume":"2","author":"Reding","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1538-7836.2003.00251.x","article-title":"Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII","volume":"1","author":"Reding","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1182\/blood.V86.5.1811.bloodjournal8651811","article-title":"Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site","volume":"86","author":"Scandella","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V86.2.797.bloodjournal862797","article-title":"A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin","volume":"86","author":"Schwartz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib37","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1016\/S0021-9258(19)81497-7","article-title":"Localization of the binding site for a factor VIII activity neutralizing antibody to amino acid residues Asp1663-Ser1669","volume":"263","author":"Shima","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2006.09.034_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V98.1.13","article-title":"Structure of a factor VIII C2 domain-immunoglobulin G4\u03ba Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII","volume":"98","author":"Spiegle","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V99.4.1215","article-title":"3-dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography","volume":"99","author":"Stoilova-McPhie","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/j.1460-2075.1982.tb01343.x","article-title":"Monoclonal antibody against the carboxy terminal peptide pp60src of Rous sarcoma virus reacts with native pp60src","volume":"1","author":"Tamura","year":"1982","journal-title":"Embo J."},{"key":"10.1016\/j.molimm.2006.09.034_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V96.2.540.014k20_540_545","article-title":"Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain","volume":"96","author":"Van den Brink","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2006.09.034_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2006.09.034_bib43","doi-asserted-by":"crossref","first-page":"12677","DOI":"10.1074\/jbc.M311042200","article-title":"Residues 110\u2013126 in the A1 domain of factor VIII contain a Ca2+ binding site required for Cofactor activity","volume":"279","author":"Wakabayashi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2006.09.034_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0038-1646563","article-title":"Localization of anti-factor VIII monoclonal antibodies determined by recombinant peptides","volume":"61","author":"Ware","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2006.09.034_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.V92.1.136.413k35_136_142","article-title":"Some human inhibitor antibodies interfere with factor VIII binding to factor IX","volume":"92","author":"Zhong","year":"1998","journal-title":"Blood"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589006006353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589006006353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:55Z","timestamp":1758979315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589006006353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0161589006006353"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2006.09.034","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2006.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}